Search
for
Sort by
Research 211–240 of 518
- Etiopathogenesis of Alopecia Areata
- Journal of Population Therapeutics and Clinical Pharmacology
- Hidradenitis suppurativa: a new therapeutic approach for an old disease
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- 186 Mechanistic insights into Ritlecitinib-mediated immunomodulation in Alopecia Areata
- A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
- Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- Application of Baricitinib in Dermatology
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Patient-reported outcome improvements following scalp hair regrowth among patients with Alopecia Areata: analysis of the ALLEGRO-2b/3 trial
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Janus kinase inhibitors for alopecia areata: A narrative review
- Interleukin-15 is a hair follicle immune privilege guardian
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Therapeutic update on alopecia areata: a critical review of standard and emerging targeted therapies
- Network pharmacology, molecular docking, and dynamics reveal the mechanisms of Hejie Shengfa Decoction against alopecia areata
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study